Log In
BCIQ
Print this Print this
 

VBY-285

  Manage Alerts
Collapse Summary General Information
Company Virobay Inc.
DescriptionCathepsin S inhibitor
Molecular Target Cathepsin S
Mechanism of ActionCathepsin S inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune disorders
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today